FDA releases its latest batch of Warning Letters that includes Balamurali K. Ambati, Haw Par Healthcare, Metuchen Pharmaceuticals, Polimeros y Servici...
An annual Gallup Work and Education poll shows the pharmaceutical industry is the most poorly regarded industry by Americans, falling below even the f...
FDA says a Tennessee federal judge entered a consent decree against two companies to prohibit them from distributing drugs, dietary supplements, or me...
FDA Review has posted the Federal Register notices for the week ending 8/30/2019.
FDA Review posts product approval summaries for the week ending 8/30/2019.
Novartis says it will file a BLA and seek other global approvals for its leukemia drug Arzerra (ofatumumab) and its use in treating relapsing forms of...
Federal Register notice: FDA requests nominations for voting members to serve on CDRHs Device Good Manufacturing Practice Advisory Committee and the M...